ELK1 and prostate carcinoma: PTL was found to be particularly cytotoxic to prostatic cancer stem cells (or tumor-initiating cells, TICs), thus underscoring ELK1’s role in early PCa tumorigenesis and how its targeting may be a potential approach [172].